Effects of Different Surgical Methods to Treat Obesity (DEOSH)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01785134 |
Recruitment Status :
Completed
First Posted : February 7, 2013
Results First Posted : October 2, 2014
Last Update Posted : October 2, 2014
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Obesity Type 2 Diabetes Insulin Sensitivity | Procedure: Omentectomy Procedure: Gastric bypass operation | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 81 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Triple (Participant, Investigator, Outcomes Assessor) |
Primary Purpose: | Treatment |
Official Title: | Metabolic Effects of Different Surgical Methods to Treat Obesity |
Study Start Date : | May 2006 |
Actual Primary Completion Date : | December 2011 |
Actual Study Completion Date : | December 2011 |

Arm | Intervention/treatment |
---|---|
Sham Comparator: Control
Gastric bypass operation without omentectomy.
|
Procedure: Gastric bypass operation |
Active Comparator: Omentectomy
Gastric bypass operation in conjunction with removal of greater omentum
|
Procedure: Omentectomy Procedure: Gastric bypass operation |
- Insulin Sensitivity at 2 Years [ Time Frame: 2 years postoperative ]Insulin sensitivity measured by hyperinsulinemic euglycemic clamp
- Body Composition at Two Years [ Time Frame: 2 years postoperative ]
- Blood Pressure at 2 Years [ Time Frame: 2 years postoperative ]
- Body Mass Index at 2 Years [ Time Frame: 2 years postoperative ]
- Blood Lipids [ Time Frame: 2 years postoperative ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 70 Years (Adult, Older Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Body mass index over 40 kg/m2
Body mass index over 35 kg/m2 with obesity associated co-morbidities such as type 2 diabetes and/or additional cardiovascular risk factors -
Exclusion Criteria:
-

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01785134
Sweden | |
Södertälje Hospital | |
Södertälje, Stockholm, Sweden, 15286 | |
Ersta Hospital | |
Stockholm, Sweden, 11691 | |
Karolinska University Hospital Huddinge | |
Stockholm, Sweden, 14186 | |
Danderyds Hospital | |
Stockholm, Sweden, 18288 |
Principal Investigator: | Erik Näslund, MD, PhD | Karolinska Institutet | |
Study Director: | Peter Arner, MD, PhD | Karolinska Institutet | |
Study Chair: | Johan Hoffstedt, MD, PhD | Karolinska Institutet |
Responsible Party: | Erik Näslund, Professor, MD, PhD, Karolinska Institutet |
ClinicalTrials.gov Identifier: | NCT01785134 |
Other Study ID Numbers: |
CT20110061 CT20110061 ( Registry Identifier: Karolinska Clinical Trial Registration ) |
First Posted: | February 7, 2013 Key Record Dates |
Results First Posted: | October 2, 2014 |
Last Update Posted: | October 2, 2014 |
Last Verified: | September 2014 |
Obesity Bariatric Surgery Insulin Sensitivity |
Obesity Insulin Resistance Hypersensitivity Overnutrition Nutrition Disorders Overweight |
Body Weight Immune System Diseases Hyperinsulinism Glucose Metabolism Disorders Metabolic Diseases |